1 Eculizumab Market Overview 1.1 Product Overview of Eculizumab 1.2 Classification and Application of Eculizumab 1.3 Europe Eculizumab Market Regional Analysis 1.3.1 UK Market Present Situation Analysis 1.3.2 Germany Market Present Situation Analysis 1.3.3 France Market Present Situation Analysis 1.3.4 Italy Market Present Situation Analysis 1.3.5 Russia Market Present Situation Analysis 1.3.6 Benelux Market Present Situation Analysis 1.3.7 Spain Market Present Situation Analysis 1.3.8 Poland Market Present Situation Analysis 1.3.9 Ukraine Market Present Situation Analysis 1.4 Eculizumab Industry Development Factors Analysis 1.4.1 Eculizumab Industry Development Opportunities Analysis 1.4.2 Eculizumab Industry Development Challenges Analysis 1.5 Eculizumab Consumer Behavior Analysis 2 Europe Eculizumab Competition by Players 2.1 Europe Eculizumab Sales (Unit) and Market Share (%) by Players 2.2 Europe Eculizumab Revenue (Million USD) and Share by Players (2016-2017) 2.3 Europe Eculizumab Price (USD/Unit) by Players (2016-2017) 2.4 Europe Eculizumab Gross Margin by Players (2016-2017) 3 Europe Eculizumab Competition by Types 3.1 Europe Eculizumab Sales (Unit) and Market Share (%) by Types 3.2 Europe Eculizumab Revenue (Million USD) and Share by Type (2012-2017) 3.3 Europe Eculizumab Price (USD/Unit) by Type (2012-2017) 3.4 Europe Eculizumab Gross Margin by Type (2012-2017) 3.5 UK Eculizumab Sales (Unit) and Market Share (%) by Type 3.6 Italy Eculizumab Sales (Unit) and Market Share (%) by Type 3.7 Germany Eculizumab Sales (Unit) and Market Share (%) by Type 3.8 France Eculizumab Sales (Unit) and Market Share (%) by Type 3.9 Russia Eculizumab Sales (Unit) and Market Share (%) by Type 3.10 Benelux Eculizumab Sales (Unit) and Market Share (%) by Type 3.11 Spain Eculizumab Sales (Unit) and Market Share (%) by Type 3.12 Poland Eculizumab Sales (Unit) and Market Share (%) by Type 3.12 Ukraine Eculizumab Sales (Unit) and Market Share (%) by Type 4 Europe Eculizumab Competition by Application 4.1 Europe Eculizumab Sales (Unit) and Market Share (%) by Application 4.2 Europe Eculizumab Revenue (Million USD) and Share by Application (2012-2017) 4.3 Europe Eculizumab Price (USD/Unit) by Application (2012-2017) 4.4 Europe Eculizumab Gross Margin by Application (2012-2017) 4.5 UK Eculizumab Sales (Unit) and Market Share (%) by Application 4.6 Italy Eculizumab Sales (Unit) and Market Share (%) by Application 4.7 Germany Eculizumab Sales (Unit) and Market Share (%) by Application 4.8 France Eculizumab Sales (Unit) and Market Share (%) by Application 4.9 Russia Eculizumab Sales (Unit) and Market Share (%) by Application 4.10 Benelux Eculizumab Sales (Unit) and Market Share (%) by Application 4.11 Spain Eculizumab Sales (Unit) and Market Share (%) by Application 4.12 Poland Eculizumab Sales (Unit) and Market Share (%) by Application 4.13 Ukraine Eculizumab Sales (Unit) and Market Share (%) by Application 5 Europe Eculizumab Production Market Analysis by Region 5.1 Europe Eculizumab Production (Unit) and Market Share (%) by Region 5.1.1 UK Eculizumab Market Production Present Situation Analysis 5.1.2 Germany Eculizumab Market Production Present Situation Analysis 5.1.3 Italy Eculizumab Market Production Present Situation Analysis 5.1.4 France Eculizumab Market Production Present Situation Analysis 5.1.5 Russia Eculizumab Market Production Present Situation Analysis 5.1.6 Benelux Eculizumab Market Production Present Situation Analysis 5.1.7 Spain Eculizumab Market Production Present Situation Analysis 5.1.8 Poland Eculizumab Market Production Present Situation Analysis 5.1.9 Ukraine Eculizumab Market Production Present Situation Analysis 5.2 Europe Eculizumab Production Value (Million USD) and Share by Region (2012-2017) 5.3 Europe Eculizumab Price (USD/Unit) by Region (2012-2017) 5.4 Europe Eculizumab Gross Margin by Region (2012-2017) 6 Europe Eculizumab Sales Market Analysis by Region 6.2.1 UK Eculizumab Market Consumption Present Situation Analysis 6.2.2 Germany Eculizumab Market Consumption Present Situation Analysis 6.2.3 Italy Eculizumab Market Consumption Present Situation Analysis 6.2.4 France Eculizumab Market Consumption Present Situation Analysis 6.2.5 Russia Eculizumab Market Consumption Present Situation Analysis 6.2.6 Benelux Eculizumab Market Consumption Present Situation Analysis 6.2.7 Spain Eculizumab Market Consumption Present Situation Analysis 6.2.8 Poland Eculizumab Market Consumption Present Situation Analysis 7 Imports and Exports Market Analysis 7.1 UK Eculizumab Imports and Exports Analysis (2012-2017) 7.2 Germany Eculizumab Imports and Exports Analysis (2012-2017) 7.3 Italy Eculizumab Imports and Exports Analysis (2012-2017) 7.4 France Eculizumab Imports and Exports Analysis (2012-2017) 7.5 Russia Eculizumab Imports and Exports Analysis (2012-2017) 8 Europe Eculizumab Players Profiles and Sales Data 8.1 Company one 8.1.1 Company Basic Information 8.1.2 Eculizumab Product Category 8.1.3 Company One Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.2 Company Two 8.2.1 Company Basic Information 8.2.2 Eculizumab Product Category 8.2.3 Company Two Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.3 Company Three 8.3.1 Company Basic Information 8.3.2 Eculizumab Product Category 8.3.3 Company Three Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.4 Company Four 8.4.1 Company Basic Information 8.4.2 Eculizumab Product Category 8.4.3 Company Four Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.5 Company Five 8.5.1 Company Basic Information 8.5.2 Eculizumab Product Category 8.5.3 Company Five Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.6 Company Six 8.6.1 Company Basic Information 8.6.2 Eculizumab Product Category 8.6.3 Company Six Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.7 Company Seven 8.7.1 Company Basic Information 8.7.2 Eculizumab Product Category 8.7.3 Company Seven Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.8 Company Eight 8.8.1 Company Basic Information 8.8.2 Eculizumab Product Category 8.8.3 Company Eight Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.9 Company Nine 8.9.1 Company Basic Information 8.9.2 Eculizumab Product Category 8.9.3 Company Nine Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.10 Company Ten 8.10.1 Company Basic Information 8.10.2 Eculizumab Product Category 8.10.3 Company Ten Eculizumab Sales (Volume), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 8.11 Company 11 8.12 Company 12 8.13 Company 13 8.14 Company 14 8.15 Company 15 8.16 Company 16 8.17 Company 17 8.18 Company 18 8.19 Company 18 8.20 Company 20 9 Eculizumab Upstream and Downstream Analysis 9.1 Key Raw Materials Suppliers and Price Analysis 9.2 Key Raw Materials Production and Consumption Analysis 9.4 Proportion of Manufacturing Cost Structure 9.5 Manufacturing Process Analysis 9.6Eculizumab Downstream Buyers Analysis 9.7 Eculizumab Industry Chain Analysis 9.8 Procurement Method Analysis 9.9 Customs Tariff Analysis 10Europe Eculizumab Market Forecast (2017-2022) 10.1 Europe Eculizumab Market Consumption Forecast (2017-2022) by Regions 10.1.1 UK Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.2 Germany Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.3 Italy Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.4 France Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.5 Russia Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.6 Benelux Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.7 Spain Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.8 Poland Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.1.9 Ukraine Eculizumab Market Consumption Forecast Analysis (2017-2022) 10.2 Europe Eculizumab Production Forecast by Regions (2017-2022) 10.2.1 UK Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.2 Germany Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.3 Italy Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.4 France Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.5 Russia Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.6 Benelux Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.7 Spain Eculizumab Market Production Forecast Analysis (2017-2022) 10.2.8 Poland Eculizumab Market Production Forecast Analysis (2017-2022) 10.3 Europe Eculizumab Consumption Forecast by Type (2017-2022) 10.3.1 Type 1 Eculizumab Consumption Forecast Analysis 10.3.2 Type 2 Eculizumab Consumption Forecast Analysis 10.3.3 Type 3 Eculizumab Consumption Forecast Analysis 10.3.4 Type 4 Eculizumab Consumption Forecast Analysis 10.4 Europe Eculizumab Consumption Forecast by Application (2017-2022) 10.4.1 Application 1 Eculizumab Consumption Forecast Analysis 10.4.2 Application 2 Eculizumab Consumption Forecast Analysis 10.4.3 Application 3 Eculizumab Consumption Forecast Analysis 10.4.4 Application 4 Eculizumab Consumption Forecast Analysis 11 Research Findings and Conclusion